close
  • Approved Use: Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.
Starting Aimovig Treatment
Starting Aimovig Treatment

Welcome to the Aimovig family.

We’re so glad you and your doctor decided to add Aimovig to your migraine treatment plan. Here are some ways you can get started.

aim-ally-support-90day-logo

The AimAlly™ 90-Day Start Program is a simple way to get the resources and support you need to navigate your first 3 months on Aimovig, all in one place.

  • Step 1: Filling your prescription
    aimovig-ally

    Eligible commercially insured patients can apply for an Aimovig® Copay Card.* Aimovig is available from pharmacies nationwide.

    Sign up

    Don't have commercial insurance? See other options here.

    *Terms and conditions apply.

  • Step 2: Preparing for your first dose

    Aimovig is a once-monthly injection you take at home after getting instructions from your doctor.

    Some things to keep in mind after getting your prescription:

    refridgerator

    Store it in the fridge until you’re ready to take it. Before using it, remove Aimovig from the fridge and allow it to sit at room temperature for at least 30 minutes.

    sharps-container

    Have alcohol wipes and a sharps disposal container on hand to throw away the used autoinjector. Our Instructions for Use (IFU) suggest cleaning with alcohol wipes, but cleaning with soap and water may be an alternative. If you’re out of alcohol wipes, please consult your doctor.

    Aimovig comes in two doses: 70 mg/mL and 140 mg/mL. Both doses come in an easy-to-use autoinjector.

    70-mg-pen 140-mg-pen

    96%

    of patients found the autoinjector device easy to use.*

    *Based on a study of about 200 adults with migraine who performed a simulated injection. 

    70-ifu

    The Instructions for Use cover everything you need to know about injecting Aimovig. For a quick overview, see the reference guides or the video below.

    video poster

    Watch this overview video about
    how to inject Aimovig

    Learn more about injection
  • Step 3: What to expect

    How effective is Aimovig?
    In clinical studies, Aimovig was proven to help prevent monthly migraine days. Some patients saw their number reduced by half or more. But remember, a reduction in migraine days doesn’t mean you won’t experience any at all.

    What will Aimovig feel like for you?
    Everyone’s body is different, and the exact response will vary from person to person. Your doctor will suggest a time to check in on your response.

    sms-tracker

    Through the Aimovig AimAlly™ 90-Day Start Program, you’ll receive personalized support via email with resources, information, and tools to let you know what to expect throughout your first 3 months on Aimovig.

    sms-tracker

    You can track every change, big or small, by responding to a daily text message with the free Daily Text Migraine Tracker. Tracking your migraine can help you and your doctor recognize changes and patterns and best assess your treatment plan.
    Sign up and get tracking!

Frequently asked questions

  • Who do I contact if I need help with the autoinjector or my injection?
    If you need more information or help, please visit the How to Take Aimovig page or call 1-800-77-AMGEN (1-800-772-6436)
  • Who can I talk to if I have questions?
    Call Aimovig Ally™ support at 1-833-AIMOVIG (1-833-246-6844), 8AM–9PM ET, Mon–Fri.

Contact us here

1-833-AIMOVIG (1-833-246-6844)

8AM–9PM ET, Mon–Fri

+ +

Important Safety Information

Who should not use Aimovig®?
Do not use Aimovig if you are allergic to erenumab-aooe or any ingredients in

Who should not use Aimovig? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

 

Important Safety Information

Who should not use Aimovig®? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements. What are possible side effects of Aimovig®? Aimovig® may cause serious side effects, including:
  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation or constipation associated with symptoms such as severe or constant belly pain, vomiting, swelling of belly or bloating.
  • High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig®. Contact your healthcare provider if you have an increase in blood pressure.
The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation. These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Click here for the full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.
References: 1. Parsabiv® (etelcalcetide) prescribing information, Amgen. 2. Data on file, Amgen; [Summary of Clinical Efficacy; 2015]. 3. Alexander ST, et al. Mol Pharmacol. 2015;88:853-865. 4. Data on file, Amgen; [Report R20130052, 2014]. 5. Chen P, et al. CPT Pharmacometrics Syst Pharmacol. 2016;5:484-494. 6. Sensipar® (cinacalcet) prescribing information, Amgen. 7. Ma JN, et al. J Pharmacol Exp Ther. 2011;337:275-284.